A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Condition: Persistent AsthmaInterventions: Drug: Beclomethasone dipropionate breath-actuated inhaler; Drug: Placebo breath-actuated inhaler; Drug: albuterol/salbutamolSponsors: Teva Branded Pharmaceutical Products, R&D Inc.; Teva Pharmaceutical IndustriesRecruiting - verified September 2014

http://clinicaltrials.gov/ct2/show/NCT02040779?lup_s=09%2F02%2F2014&lup_d=30

Source: ClinicalTrials.gov - January 16, 2014 Category: Research Source Type: clinical trials